COYA offering history
Every offering-related filing in Coya Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 227 filings back to Jan 5, 2021.
| Date | Filing | What it means | |
|---|---|---|---|
| May 12, 2026 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Mar 20, 2026 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Mar 20, 2026 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Mar 16, 2026 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Jan 30, 2026 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 27, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Oct 27, 2025 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Oct 23, 2025 | 424B5 → | EXECUTED | Shelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm) |
| Aug 19, 2025 | 424B7 → | UPDATE | Resale prospectus — existing holders registering to sell |
| Aug 19, 2025 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Aug 12, 2025 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Nov 29, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Nov 29, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Nov 20, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Oct 22, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jun 24, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jun 21, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jun 14, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| May 20, 2024 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| Jan 16, 2024 | 424B3 → | UPDATE | Prospectus update — often a resale registration, not necessarily new capital |
| Jan 12, 2024 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Jan 4, 2024 | S-3 → | REGISTERED | S-3 registration — capacity to sell shares, not a sale yet |
| Dec 6, 2023 | 8-K → | EXECUTED | Unregistered share sale disclosed (8-K item 3.02) |
| May 12, 2023 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| May 10, 2023 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 30, 2022 | 424B4 → | EXECUTED | Final prospectus — offering priced (typical for IPOs and marketed share deals) |
| Dec 28, 2022 | EFFECT → | EFFECTIVE | SEC declared a registration effective — selling can begin |
| Dec 13, 2022 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Dec 6, 2022 | FWP → | MARKETING | Free-writing prospectus — offering being marketed |
| Dec 5, 2022 | S-1/A → | REGISTERED | S-1/A registration — capacity to sell shares, not a sale yet |
| Nov 18, 2022 | S-1 → | REGISTERED | S-1 registration — capacity to sell shares, not a sale yet |
Two honest limits. (1) A 424B takedown can price shares or notes— EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.
COYA offering FAQ
When did COYA last execute an offering?
Per SEC filings, Coya Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2026-05-12. Note a 424B takedown can price shares or notes (debt) — the linked document says which.
When did COYA last announce or register an offering?
The most recent registration is a S-3 filed 2026-03-16. A registration is capacity to sell shares — not a sale.
Does an offering always mean dilution?
Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.